DeAngelo, D. J., Pullarkat, V., Piris-Villaespesa, M., George, T. I., Patel, J. L., Ustun, C., Bose, P., Heaney, M. L., Pilla, A., Massaro, M., Exter, B., Jolin, H. A., Mikhak, Z., & Tashi, T. (2022). P1049: A Phase 2 Study of Bezuclastinib (CGT9486), a Novel, Highly Selective, Potent Kit D816V Inhibitor, in Adults With Advanced Systemic Mastocytosis (Apex): Methods, Baseline Data, and Early Insights. HemaSphere, 6, 939–940. https://doi.org/10.1097/01.hs9.0000847064.38588.9b
Subjects:
Role of Mast Cells in Immunoregulation and Disease
(OpenAlex Topic)
Hypereosinophilic Syndrome and Related Disorders
(OpenAlex Topic)
Click Chemistry in Chemical Biology and Drug Development
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1097/01.hs9.0000847064.38588.9b
Journal:
Publication Date:
Data Source:
OpenAlex
Source Link: